Most recently, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor functions like a scavenger https://christi370vuo9.theisblog.com/profile